Endologix Inc. to Report Second Quarter 2012 Financial Results and Provide Operational and Product Pipeline Updates on July 26, 2012  
7/23/2012 9:52:03 AM

IRVINE, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its second quarter 2012 financial results, which will take place on Thursday, July 26, 2012 after the close of the market.